Brandi L. Roberts
2021 - Longboard Pharmaceuticals
In 2021, Brandi L. Roberts earned a total compensation of $1.3M as Chief Financial Officer at Longboard Pharmaceuticals.
Compensation breakdown
| Bonus | $30,000 |
|---|---|
| Non-Equity Incentive Plan | $153,509 |
| Option Awards | $765,266 |
| Salary | $373,269 |
| Other | $11,792 |
| Total | $1,333,836 |
Roberts received $765.3K in option awards, accounting for 57% of the total pay in 2021.
Roberts also received $30K in bonus, $153.5K in non-equity incentive plan, $373.3K in salary and $11.8K in other compensation.
Rankings
In 2021, Brandi L. Roberts' compensation ranked 7,725th out of 12,406 executives tracked by ExecPay. In other words, Roberts earned more than 37.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,725 out of 12,406 | 38th |
Division Manufacturing | 3,405 out of 5,492 | 38th |
Major group Chemicals And Allied Products | 1,510 out of 2,368 | 36th |
Industry group Drugs | 1,344 out of 2,089 | 36th |
Industry Pharmaceutical Preparations | 990 out of 1,536 | 36th |
Source: SEC filing on April 13, 2022.
Roberts' colleagues
We found two more compensation records of executives who worked with Brandi L. Roberts at Longboard Pharmaceuticals in 2021.
News
Longboard Pharmaceuticals CEO Kevin Lind's 2023 pay jumps 36% to $2.1M
April 12, 2024
Longboard Pharmaceuticals CEO Kevin Lind's 2022 pay jumps 72% to $1.5M
April 11, 2023
Longboard Pharmaceuticals CFO Brandi Roberts receives $1.3M in 2021
April 13, 2022
BioTime CFO Brandi Roberts receives $948K in 2019
August 7, 2020